1. Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.

    Journal of Infectious Diseases 214(5):762 (2016) PMID 27296848

    Three full doses of RTS,S/AS01 malaria vaccine provides partial protection against controlled human malaria parasite infection (CHMI) and natural exposure. Immunization regimens, including a delayed fractional third dose, were assessed for potential increased protection against malaria and immun...
  2. Association of synovial inflammation and inflammatory mediators with glenohumeral rotator cuff pathology.

    Journal of Shoulder and Elbow Surgery 25(6):989 (2016) PMID 26775747

    We hypothesized that patients with full-thickness rotator cuff tears would have greater synovial inflammation compared with those without rotator cuff tear pathology, with gene expression relating to histologic findings. Synovial sampling was performed in 19 patients with full-thickness rotator ...
  3. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.

    Journal of Autoimmunity 70:22 (2016) PMID 27055777

    The serology of patients with Rheumatoid arthritis (RA) is characterized by persistently raised levels of autoantibodies: Rheumatoid Factors (RhF) against Fc of IgG, and to citrullinated (Cit) protein/peptide sequences: ACPA, recognizing multiple Cit-sequences. B cell depletion therapy based on ...
  4. Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial.

    Annals of the Rheumatic Diseases 75(4):709 (2016) PMID 26359449 PMCID PMC4819608

    To examine whether baseline anti-cyclic citrullinated peptide-2 (CCP2) antibody status and concentration correlated with clinical outcomes in patients treated with abatacept or adalimumab on background methotrexate (MTX) in the 2-year AMPLE (Abatacept versus adaliMumab comParison in bioLogic-naï...
  5. Biomarkers to guide clinical therapeutics in rheumatology?

    Current Opinion in Rheumatology 28(2):168 (2016) PMID 26720904 PMCID PMC4770786

    The use of biomarkers in rheumatology can help identify disease risk, improve diagnosis and prognosis, target therapy, assess response to treatment, and further our understanding of the underlying pathogenesis of disease. Here, we discuss the recent advances in biomarkers for rheumatic disorders...
  6. Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model.

    Journal of diabetes research 2016:9083103 (2016) PMID 27069933 PMCID PMC4812430

    Type 1 diabetes is an autoimmune disease in which insulin-producing pancreatic islet β cells are the target of self-reactive B and T cells. T cells reactive with epitopes derived from insulin and/or IGRP are critical for the initiation and maintenance of disease, but T cells reactive with other ...
  7. Anti-Insulin Immune Responses Are Detectable in Dogs with Spontaneous Diabetes.

    PLoS ONE 11(3):e0152397 (2016) PMID 27031512 PMCID PMC4816536

    Diabetes mellitus occurs spontaneously in dogs. Although canine diabetes shares many features with human type-1 diabetes, there are differences that have cast doubt on the immunologic origin of the canine disease. In this study, we examined whether peripheral immune responses directed against is...
  8. Absence of keratin 8 or 18 promotes antimitochondrial autoantibody formation in aging male mice.

    FASEB Journal 29(12):5081 (2015) PMID 26399787 PMCID PMC4653051

    Human mutations in keratin 8 (K8) and keratin 18 (K18), the intermediate filament proteins of hepatocytes, predispose to several liver diseases. K8-null mice develop chronic liver injury and fragile hepatocytes, dysfunctional mitochondria, and Th2-type colitis. We tested the hypothesis that auto...
  9. Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

    Journal of Clinical Microbiology 53(12):3834 (2015) PMID 26447113 PMCID PMC4652118

    The current standard for laboratory diagnosis of Lyme disease in the United States is serologic detection of antibodies against Borrelia burgdorferi. The Centers for Disease Control and Prevention recommends a two-tiered testing algorithm; however, this scheme has limited sensitivity for detecti...
  10. Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis.

    Arthritis & rheumatology (Hoboken, N.J.) 67(11):2877 (2015) PMID 26227989 PMCID PMC4626401

    Anti-citrullinated protein antibodies (ACPAs) are characteristic of rheumatoid arthritis (RA). However, their presence years before the onset of clinical RA is perplexing. Although multiple putative citrullinated antigens have been identified, no studies have demonstrated the specific capacity o...
  11. Decade in review-technology: Technological advances transforming rheumatology.

    Nature Reviews: Rheumatology 11(11):626 (2015) PMID 26439404 PMCID PMC4769868

  12. Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors and mortality.

    Rheumatology 54(9):1587 (2015) PMID 25854268 PMCID PMC4536858

    To examine whether vascular calcifications on hand films in RA might aid in determining mortality risk. Hand radiographs from 906 RA patients were scored as positive or negative for vascular calcifications. Patient characteristics associated with vascular calcifications were assessed using multi...
  13. Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.

    Arthritis & rheumatology (Hoboken, N.J.) 67(9):2311 (2015) PMID 25988241 PMCID PMC4551571

    To evaluate the incidence of cardiovascular disease (CVD) morbidity and mortality over the course of 10 years among the more than 160,000 postmenopausal women in the Women's Health Initiative (WHI) in relation to self-reported rheumatoid arthritis (RA), taking disease-modifying antirheumatic dru...
  14. Mass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myeloma.

    Cancer Immunology Research 3(6):650 (2015) PMID 25711758 PMCID PMC4457663

    It would be very beneficial if the status of cancers could be determined from a blood specimen. However, peripheral blood leukocytes are very heterogeneous between individuals, and thus high-resolution technologies are likely required. We used cytometry by time-of-flight and next-generation sequ...
  15. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.

    Annals of the Rheumatic Diseases 74(3):579 (2015) PMID 24297382 PMCID PMC4345988

    A hallmark of rheumatoid arthritis (RA) is the development of autoantibodies targeting proteins that contain citrulline. Anticitrullinated protein antibodies (ACPAs) are currently detected by the commercial cyclic citrullinated peptide (CCP) assay, which uses a mix of cyclised citrullinated pept...
  16. Sequencing the functional antibody repertoire--diagnostic and therapeutic discovery.

    Nature Reviews: Rheumatology 11(3):171 (2015) PMID 25536486 PMCID PMC4382308

    The development of high-throughput DNA sequencing technologies has enabled large-scale characterization of functional antibody repertoires, a new method of understanding protective and pathogenic immune responses. Important parameters to consider when sequencing antibody repertoires include the ...
  17. Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.

    Arthritis & rheumatology (Hoboken, N.J.) 67(3):645 (2015) PMID 25417811

    Malondialdehyde-acetaldehyde (MAA) adducts are a product of oxidative stress associated with tolerance loss in several disease states. This study was undertaken to investigate the presence of MAA adducts and circulating anti-MAA antibodies in patients with rheumatoid arthritis (RA). Synovial tis...
  18. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.

    Journal of Periodontology 86(2):222 (2015) PMID 25299390

    This study examines: 1) alveolar bone loss (ABL), a hallmark of periodontitis, in anti-citrullinated protein antibody (ACPA)-positive rheumatoid arthritis (RA) patients versus control patients with osteoarthritis (OA); and 2) the association of ABL with RA disease activity and ACPA concentration...
  19. The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression.

    Arthritis research & therapy 18(1):61 (2015) PMID 26968800 PMCID PMC4788924

    Rheumatoid arthritis (RA) is often characterized by the presence of rheumatoid factor, anti-citrullinated protein antibodies, and bone erosions. Current therapies can compromise immunity, leading to risk of infection. The interleukin-20 receptor (IL-20R) axis comprising IL-19, IL-20, and IL-24 a...
  20. Contribution of mast cell-derived interleukin-1β to uric acid crystal-induced acute arthritis in mice.

    Arthritis & rheumatology (Hoboken, N.J.) 66(10):2881 (2014) PMID 24943488 PMCID PMC4443497

    Gouty arthritis is caused by the precipitation of monosodium urate monohydrate (MSU) crystals in the joints. While it has been reported that mast cells (MCs) infiltrate gouty tophi, little is known about the actual roles of MCs during acute attacks of gout. This study was undertaken to assess th...